Kaspa has been under heavy pressure, and price action over the past few days has pushed sentiment into extreme fear. That’s the backdrop for a bold statement fromKaspa has been under heavy pressure, and price action over the past few days has pushed sentiment into extreme fear. That’s the backdrop for a bold statement from

$0.03 Kaspa? One Analyst Is Ready to Go All-In With $100,000

4 min read

Kaspa has been under heavy pressure, and price action over the past few days has pushed sentiment into extreme fear. That’s the backdrop for a bold statement from Travladd Crypto, who said that if KAS drops below $0.03, he plans to deploy $100,000 in one shot. His message was simple and emotional, but it carried a deeper point: if Kaspa fails at that level, then fundamentals may no longer matter in crypto at all.

The tweet landed at a moment when confidence across the market is thin. Kaspa has already sold off hard from the mid-$0.04 range, and price briefly dipped close to the level Travladd highlighted. This is no longer a calm pullback. It is a stress test.

Travladd’s comment is about conviction under pressure. He framed $0.03 as a line in the sand where fear peaks and patience disappears. His view is that Kaspa’s technology and network design should be enough to survive this phase. If price breaks down anyway, then the market may be proving that narratives and leverage matter more than substance.

That is why the tweet resonated. It reflects a wider frustration across crypto. Strong projects are getting dragged lower alongside everything else. For some traders, that creates hesitation. For others, it creates a moment to act.

Kaspa Chart Breakdown: Where Price Stands Now

The Kaspa price is trading just above $0.033, bouncing after a sharp selloff that briefly pushed price close to $0.03. This area now stands out as the most important support on the chart.

Support zones

  • $0.030–$0.031: Major psychological and structural support. A clean break below this area would likely trigger another wave of stops.
  • $0.026–$0.028: Next downside zone if $0.03 fails. This area lines up with the long wick from the recent flush.

Resistance zones

  • $0.036–$0.037: First resistance where price was rejected during the breakdown.
  • $0.040–$0.042: Strong supply zone. A reclaim would signal that sellers are losing control.
Source: CoinAnk

Right now, price is in recovery mode, but still well below prior structure.

Momentum Indicators: Early Signs of Relief

The RSI dipped into oversold territory during the selloff and has started to turn up. That points to short-term exhaustion from sellers, not a confirmed trend change. RSI still has room to move before hitting overheated levels.

The MACD shows a bullish curl forming after deep negative momentum. Histogram bars are shrinking, which hints that downside pressure is slowing. This often shows up during relief bounces, though confirmation needs follow-through.

Net positioning data shows short exposure dominating. Shorts increased aggressively during the breakdown, which helped push price lower. Over the last sessions, that pressure has stopped accelerating. This matters.

If price holds above $0.03 and pushes into resistance, short covering could fuel a sharp bounce. If support fails, those same shorts stay comfortable and downside opens fast.

Read also: Kaspa (KAS) vs BNB: This Comparison Makes BNB Look Uncomfortable

Kaspa Price Outlook

Kaspa is sitting at a crossroads.

If $0.03 holds, a rebound toward $0.036–$0.040 becomes likely. That move would fit a classic relief rally after forced selling.

If $0.03 breaks, downside could extend toward $0.028 and possibly $0.026 before buyers step in again. That scenario would fully test the conviction Travladd talked about.

For now, the market has paused just above the level that matters most. The next few sessions will decide whether this bounce grows into something larger or fades into another leg down.

Kaspa is no longer trading in a comfortable zone. It is trading where beliefs get tested.

Subscribe to our YouTube channel for daily crypto updates, market insights, and expert analysis.

The post $0.03 Kaspa? One Analyst Is Ready to Go All-In With $100,000 appeared first on CaptainAltcoin.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29